{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Pioglitazone_Hydrochloride",
  "nciThesaurus": {
    "casRegistry": "112529-15-4",
    "chebiId": "",
    "chemicalFormula": "C19H20N2O3S.HCl",
    "definition": "The hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation. (NCI05)",
    "fdaUniiCode": "JQT35NPK6C",
    "identifier": "C29367",
    "preferredName": "Pioglitazone Hydrochloride",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C98241"
    ],
    "synonyms": [
      "Actos",
      "PIOGLITAZONE HYDROCHLORIDE",
      "Pioglitazone Hydrochloride",
      "Pioglitazone.HCl"
    ]
  }
}